IN192748B - - Google Patents

Info

Publication number
IN192748B
IN192748B IN778DE2000A IN192748B IN 192748 B IN192748 B IN 192748B IN 778DE2000 A IN778DE2000 A IN 778DE2000A IN 192748 B IN192748 B IN 192748B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Ashok Rampal
Rajeev Singh Ranhuvanshi
Manoj Kumar
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to IN778DE2000 priority Critical patent/IN192748B/en
Priority to AU2001284324A priority patent/AU2001284324A1/en
Priority to EP01963298A priority patent/EP1315478A2/en
Priority to US09/941,970 priority patent/US20020081332A1/en
Priority to PCT/IB2001/001564 priority patent/WO2002017885A2/en
Publication of IN192748B publication Critical patent/IN192748B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN778DE2000 2000-08-29 2000-08-29 IN192748B (da)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IN778DE2000 IN192748B (da) 2000-08-29 2000-08-29
AU2001284324A AU2001284324A1 (en) 2000-08-29 2001-08-29 Controlled release formulation of erythromycin or a derivative thereof
EP01963298A EP1315478A2 (en) 2000-08-29 2001-08-29 Controlled release formulation of erythromycin or a derivative thereof
US09/941,970 US20020081332A1 (en) 2000-08-29 2001-08-29 Controlled release formulation of erythromycin or a derivative thereof
PCT/IB2001/001564 WO2002017885A2 (en) 2000-08-29 2001-08-29 Controlled release formulation of erythromycin or a derivative thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN778DE2000 IN192748B (da) 2000-08-29 2000-08-29

Publications (1)

Publication Number Publication Date
IN192748B true IN192748B (da) 2004-05-15

Family

ID=11097084

Family Applications (1)

Application Number Title Priority Date Filing Date
IN778DE2000 IN192748B (da) 2000-08-29 2000-08-29

Country Status (5)

Country Link
US (1) US20020081332A1 (da)
EP (1) EP1315478A2 (da)
AU (1) AU2001284324A1 (da)
IN (1) IN192748B (da)
WO (1) WO2002017885A2 (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
SK13722002A3 (sk) * 2000-02-29 2003-08-05 Teva Pharmaceutical Industries Ltd. Spôsob prípravy klaritromycínu a klaritromycínového medziproduktu, v podstate prostého oxímu a farmaceutický prostriedok, ktorý ho obsahuje
ATE432691T1 (de) * 2000-03-28 2009-06-15 Sandoz Ag Geschmackmaskierte granulierte teilchen
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6673369B2 (en) 2001-08-29 2004-01-06 Ranbaxy Laboratories Limited Controlled release formulation
US7427391B2 (en) * 2001-11-21 2008-09-23 E-Z-Em, Inc. Formulations for use in medical and diagnostic procedures
CN1652753A (zh) * 2002-04-03 2005-08-10 兰贝克赛实验室有限公司 具有改进的生物利用度的克拉霉素制剂
CA2481269A1 (en) * 2002-04-03 2003-10-09 Ranbaxy Laboratories Limited Taste masked compositions of erythromycin a and derivatives thereof
US7063862B2 (en) * 2003-06-03 2006-06-20 Biokey, Inc. Pharmaceutical composition and method for treating
WO2005004919A2 (en) * 2003-07-02 2005-01-20 Eurand, Inc. Extended release systems for macrolide antibiotics
EP1646367A4 (en) * 2003-07-21 2011-06-15 Nesher Solutions Ltd ORAL DOSAGE FORMS WITH CONTROLLED RELEASE ON GELLAN RUBBER BASE A NEW PLATFORM TECHNOLOGY FOR MAGNETIC RETENTION
WO2005009364A2 (en) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
CA2533178C (en) 2003-07-21 2014-03-11 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
AU2004258953B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
WO2005016311A1 (en) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
JP2007502294A (ja) 2003-08-12 2007-02-08 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
AU2004270170B2 (en) 2003-08-29 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
AU2004273830B2 (en) 2003-09-15 2011-03-24 Shionogi, Inc. Antibiotic product, use and formulation thereof
US8168228B2 (en) 2003-10-17 2012-05-01 Sandoz Ag Antibiotic clarithromycin micropellet compositions
US7943585B2 (en) 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
US20050260263A1 (en) * 2004-05-18 2005-11-24 Panion & Bf Biotech Inc. Sustained release formulation for sparingly soluble main drugs
JP2008505124A (ja) 2004-07-02 2008-02-21 アドバンシス ファーマスーティカル コーポレイション パルス送達用錠剤
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
WO2011125075A2 (en) * 2010-04-08 2011-10-13 Fdc Limited A novel gastroretentive delivery of macrolide
EP2671571A1 (en) * 2012-06-05 2013-12-11 Sanovel Ilac Sanayi ve Ticaret A.S. Controlled-release formulations of clarithromycin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4076804A (en) * 1975-07-18 1978-02-28 Abbott Laboratories Erythromycin therapy
GB1577196A (en) * 1977-06-03 1980-10-22 Ile De France Compositions containing erythromycin and metoclopramide
US5009897A (en) * 1988-06-24 1991-04-23 Abbott Laboratories Pharmaceutical granules and tablets made therefrom
US5705190A (en) * 1995-12-19 1998-01-06 Abbott Laboratories Controlled release formulation for poorly soluble basic drugs
US6010718A (en) * 1997-04-11 2000-01-04 Abbott Laboratories Extended release formulations of erythromycin derivatives
NZ510487A (en) * 1998-09-14 2003-04-29 Ranbaxy Lab Ltd Pharmaceutical composition comprising ciprofloxacin, sodium alginate, xanthan gum and a cross-linker polymer in a tablet or capsule form
SI20150A (sl) * 1999-02-19 2000-08-31 Lek, Tovarna Farmacevtskih In Direktno stisljivi matriks za nadzorovano sproščanje celodnevne doze klaritromicina

Also Published As

Publication number Publication date
EP1315478A2 (en) 2003-06-04
WO2002017885A2 (en) 2002-03-07
US20020081332A1 (en) 2002-06-27
WO2002017885A3 (en) 2002-09-06
AU2001284324A1 (en) 2002-03-13

Similar Documents

Publication Publication Date Title
JP2002534941A5 (da)
JP2002541912A5 (da)
AU2000236815A8 (da)
IN192748B (da)
JP2002151070A5 (da)
JP2002139933A5 (da)
JP2001213277A5 (da)
JP2003516088A5 (da)
JP2002032498A5 (da)
JP2001200923A5 (da)
JP2002019094A5 (da)
JP2001290389A5 (da)
JP2002091416A5 (da)
JP2000254307A5 (da)
JP2001344935A5 (da)
JP2002081447A5 (da)
CN3149245S (da)
CN3144928S (da)
AM949A2 (da)
CN3147660S (da)
CN3152298S (da)
CN3151268S (da)
CN3151233S (da)
CN3150564S (da)
CN3141399S (da)